Increased serum B cell-activating factor level in children with atopic dermatitis

Clinical and Experimental Dermatology

Volumn 35, Issue 6, 2010, Pages 593-598

  Jee, H M ^a   Kim, K W ^b   Hong, J Y ^b   Sohn, M H ^b   Kim, K E ^b  

^a CHA University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; IMMUNOGLOBULIN E;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; EGG; EOSINOPHIL COUNT; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADOLESCENT; ANALYSIS OF VARIANCE; B-CELL ACTIVATING FACTOR; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; HUMANS; INFANT; MALE; SEVERITY OF ILLNESS INDEX;

EID: 77954343584     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03635.x     Document Type: Article

References (25)

1. Akdis CA, Akdis M, Bieber T et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 2006 118: 152 169. (Pubitemid 43946480)
2. Boguniewicz M, Leung DY. Atopic dermatitis. J Allergy Clin Immunol 2006 117: S475 80.
3. Boguniewicz M, Schmid-Grendelmeier P, Leung DY. Atopic dermatitis. J Allergy Clin Immunol 2006 118: 40 3.
4. Eigenmann PA. Clinical features and diagnostic criteria of atopic dermatitis in relation to age. Pediatr Allergy Immunol 2001 12 (Suppl. 14 69 74.
5. Leung DY. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1999 104: S99 108.
6. El Biaze M, Boniface S, Koscher V et al. T cell activation, from atopy to asthma: more a paradox than a paradigm. Allergy 2003 58: 844 853.
7. Grewe M, Gyufko K, Schopf E, Krutmann J. Lesional expression of interferon-gamma in atopic eczema. Lancet 1994 343: 25 6.
8. Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994 94: 870 876.
9. Toda M, Leung DY, Molet S et al. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 2003 111: 875 881.
10. Mackay F, Browning JL. BAFF a fundamental survival factor for B cells. Nat Rev Immunol 2002 2: 465 475.
11. Kang JS, Yoon YD, Ahn JH et al. B cell-activating factor is a novel diagnosis parameter for asthma. Int Arch Allergy Immunol 2006 141: 181 188.
12. Huard B, Arlettaz L, Ambrose C et al. BAFF production by antigen-presenting cells provides T cell co-stimulation. Int Immunol 2004 16: 467 475.
13. Krumbholz M, Theil D, Derfuss T et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 2005 201: 195 200.
14. Sutherland AP, Ng LG, Fletcher CA et al. BAFF augments certain Th1-associated inflammatory responses. J Immunol 2005 174: 5537 5544.
15. Mackay F, Schneider P. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties. Cytokine Growth Factor Rev 2008 19: 263 276.
16. Matsushita T, Fujimoto M, Echigo T et al. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis. Exp Dermatol 2008 17: 197 202.
17. Hanifin JM. Diagnostic criteria for atopic dermatitis: consider the context. Arch Dermatol 1999 135: 1551.
18. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993 186: 23 31.
19. Kunz B, Oranje AP, Labreze L et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997 195: 10 19.
20. Johansson SG, Bieber T, Dahl R et al. Revised nomenclature for allergy for global use. Report of the Nomenclature Review Committee of the World Allergy Organization, October, 2003. J Allergy Clin Immunol 2004 113: 832 836. (Pubitemid 38608590)
21. Moon EY, Ryu SK. TACI:Fc scavenging B cell activating factor (BAFF) alleviates ovalbumin-induced bronchial asthma in mice. Exp Mol Med 2007 39: 343 352.
22. Bardana EJ Jr. Immunoglobulin E-(IgE) and non-IgE-mediated reactions in the pathogenesis of atopic eczema/dermatitis syndrome (AEDS). Allergy 2004 59 (Suppl. 78 25 9.
23. Akdis CA, Akdis M, Simon D et al. Role of T cells and cytokines in the intrinsic form of atopic dermatitis. Curr Probl Dermatol 1999 28: 37 44.
24. Kato A, Peters A, Suh L et al. Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 2008 121: 1385 1392. 92 e1-2.
25. Eigenmann PA, Sicherer SH, Borkowski TA et al. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 1998 101: E8.